Navigation Links
New data improve understanding of breast cancer's multiple varieties
Date:5/3/2012

id. "On the other hand, tumors that were hormone receptor negative and HER2 negative had lower MUC1 protein and mRNA expression compared to other subtypes."

The different molecular subtypes of breast cancer, mainly defined by the presence or absence of estrogen receptor and the cell-surface protein HER2, have important implications for the treatment and prognosis of breast cancer. One goal of the current study was to evaluate the frequency of mucin-1 expression among the different subtypes, to provide hints as to which subtypes are most likely to benefit from a therapy that targets mucin-1.

"We could demonstrate that high mucin-1 is more frequently observed in hormone-receptor positive and HER2 negative breast cancer," Dr Sinn said. "The lowest levels were detected in triple negative cases, i.e. tumors without evidence of estrogen-receptor and HER2. However, even in triple negative breast cancers, mucin-1 was high in 44% of cases."

This data indicates an important role for mucin-1 in breast cancer biology that differs among the various breast cancer subtypes, Dr Sinn said. "The results are of particular interest because currently there are tumor vaccines being tested in clinical trials that induce the patient's immune system to attack cells that carry mucin-1. These agents have already shown efficacy in lung cancer and could be also promising agents in the treatment of breast cancer."

When the researchers correlated the expression of the protein and mRNA with the patient's response to chemotherapy, they found that low levels of expression were predictive for pathological complete response -or eradication of the invasive tumor. This correlation held true for the overall population and in the subgroups of hormone receptor positive, HER2-negative and HR+/HER2- tumors.

"MUC1 is frequently expressed in a large cohort of breast cancers, especially in hormone-receptor positive tumors," the researchers observed. "Its evaluatio
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. FSU joins coalition working to improve nations power grid
2. For insulin sensitive overweight patients, 1 session of exercise improves metabolic health
3. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
4. Researchers study how pistachios may improve heart health
5. Scientists identify gene that may contribute to improved rice yield
6. Research about plant viruses could lead to new ways to improve crop yields
7. RNA molecules, delivery system improve vaccine responses, effectiveness
8. British scientists go cloud-hopping in the Pacific to improve climate predictions
9. How eating fruit and vegetables can improve cancer patients response to chemotherapy
10. USAID grant awarded to improve food security in Africa
11. UI researchers help to improve carbon measurements in global climate studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... YORK , March 31, 2015  Elephant Talk ... "Company"), a global provider of Software Defined Network Architecture ... today announced total revenue of approximately $20.4 million for ... a restated $19.5 million for the year ended December ... calendar 2014, the Company had completed its multi-year transition ...
(Date:3/26/2015)... 2015 The Granite Club, ... athletic club, today announced it has implemented a state-of-the-art ... movement for members and staff, while restricting access to ... we selected FST,s IMID Access system because it has ... members and staff, in addition to unparalleled security," said ...
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... A mother,s iron deficiency early in pregnancy may have ... the child, even if the lack of iron is not ... Rochester Medical Center study published in the scientific journal ... might not notice or treat mild or moderate iron deficiency, ...
... 2011) - An animal,s behavior is probably its ... Its behavior involves processes internal to the animalgenetics, neurobiology, ... social surroundings. According to the book,s authors, "Animal behavior ... sparked when neurons fire in response to stimuli in ...
... In recent years, researchers have worked to develop more ... in Afghanistan or Iraq with missing arms or legs. ... entering the body through the space where the device ... area) where the bacteria would enter the body, and ...
Cached Biology News:Pre-conception and early pregnancy iron deficiency harms brain 2Pre-conception and early pregnancy iron deficiency harms brain 3New book on animal behavior provides integrated view 2Nanomodified surfaces seal leg implants against infection 2
(Date:4/23/2015)... Prospects for Leading Companies in ... Details   We predict the global healthcare ... in 2015 and will grow at a CAGR of 6.3% ... around the world and increasing functional requirements for healthcare packaging ... global healthcare packaging market. A global ageing population, ...
(Date:4/23/2015)... Proove Biosciences , a commercial ... to announce the launch of Proove Non-Opioid ... 62 genetic variations to predict good versus poor ... non-opioid pain medications, namely ibuprofen (brand name Advil, ... Xanax) and acetaminophen (brand name Tylenol). , ...
(Date:4/23/2015)... , April 23, 2015  Propanc Health Group ... company, focuses on the development of cancer treatments ... company lead product includes PRP, a patented formulation ... chymotrypsinogen, as well as the enzyme amylase designed ... developing a combination of anti-cancer agents working in ...
(Date:4/23/2015)... ReliantHeart's HeartAssist5® Ventricular Assist Device (VAD) precisely measure ... in real time, and this data is uploaded to ... Machine to Machine (M2M) communications for the Internet of ... can be monitored by a patient’s clinician 24/7, ... a minimum threshold, the patient can be notified immediately. ...
Breaking Biology Technology:Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 2Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 3Early Stage BioTech offers Plenty of Risk; Propanc Health Group Analyst Brief Issued by BrokerBank Securities, Inc. 2
... Nov. 20 Amicus Therapeutics,(Nasdaq: FOLD ) today ... will present a corporate update at the Lazard Capital,Markets ... Tuesday,November 27th at 11:30 am ET at The New ... of the presentation will be available to all,interested parties ...
... Massachusetts and RAMBOUILLET, France,November 20 ... model-based,vision software for musculoskeletal radiography, and ... High Resolution Digital Radiology for osteoarticular,imaging, ... joint and bone,tissues, announced today the ...
... Completion of Strategic Acquisition Reflected in Q3 Results, ... Board: ECTE) today announced financial results for the,third quarter ... 30,2007, net loss was $8,677,000 or $.70 per share, ... period in 2006. For the nine months ended,September 30, ...
Cached Biology Technology:Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 3Rapid Quantification of Osteoarthritis With a Novel, Office-Based, High-Resolution Digital Imaging Device 2Echo Therapeutics Reports Third Quarter 2007 Results 2Echo Therapeutics Reports Third Quarter 2007 Results 3Echo Therapeutics Reports Third Quarter 2007 Results 4Echo Therapeutics Reports Third Quarter 2007 Results 5Echo Therapeutics Reports Third Quarter 2007 Results 6
... Peptide Display Cloning System facilitates the display ... of bacteriophage M13 as coat protein fusions, ... peptide and its encoding DNA sequence. Peptide ... then be selected by the straightforward method ...
... protein Vtg in plasma from juvenile or male ... endocrine disrupting chemicals (EDCs) with estrogenic effects in ... screening test for the estrogenic effects of EDCs ... is a double-antibody immunometric (sandwich) EIA for analyzing ...
... PEP-055 is a 20 amino acid synthetic peptide whose sequence ... this peptide is (amino to carboxy terminus): V115 - L ... S - P - Q - V - P - N ... E133 (C) (The C-terminal cysteine has been added to facilitate conjugation ...
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
Biology Products: